Physician

Kristin Marie Gowin, M.D.

According to 2025 Medicare claims, Kristin Gowin, M.D. (NPI: 1033172895) practices rheumatology in the Asheville, NC market, with the plurality of this provider's patient population coming from Buncombe, NC. This provider's primary affiliated billing organization is ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (NPI: 1780647578; TIN: 56-1426545) and primary practice location at 28803-1700. Gowin is affiliated with the Mission Health Partners, LLC (ACO ID: A2591), participating under the MSSP model.

Gowin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 468 traditional Medicare patients, billed 131,776 HCPCS/CPT codes, and received $1,276,419 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 7,457 prescription claims across 563 beneficiaries totaling $3,792,294 in drug costs, led by Humira(Cf) Pen (Adalimumab). Open Payments data shows 105 records totaling $16,389. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $1,510,840 and ending at $1,276,419. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	701	120,527	$1,510,840
2016	737	148,047	$1,842,672
2017	859	178,785	$2,653,554
2018	641	140,469	$1,906,182
2019	737	167,125	$2,357,629
2020	616	165,629	$2,228,617
2021	542	130,085	$1,832,667
2022	562	100,658	$1,372,030
2023	516	112,174	$1,221,603
2024	468	131,776	$1,276,419

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	646	8,963	$2,883,099
2016	620	8,304	$2,931,108
2017	630	8,072	$2,972,493
2018	610	8,125	$3,212,209
2019	578	7,902	$3,496,349
2020	572	8,206	$3,557,965
2021	581	7,871	$4,016,065
2022	566	7,864	$3,990,512
2023	547	7,639	$4,154,866
2024	563	7,457	$3,792,294

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	295	664	$87
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	254	497	$12
86140	Measurement c-reactive protein for detection of infection or inflammation	256	734	$5
82565	Blood creatinine level	265	719	$5
85652	Red blood cell sedimentation rate, to detect inflammation, automated	256	725	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Humira(Cf) Pen	Adalimumab	91	2,550	$922,281
Rinvoq	Upadacitinib	97	3,246	$695,095
Skyrizi Pen	Risankizumab-Rzaa	16	1,288	$333,035
Orencia Clickject	Abatacept	38	1,064	$219,705
Enbrel	Etanercept	29	812	$199,095

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	105	$16,389	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kristin Marie Gowin, M.D.?

Tedicare shows public-source Medicare data for Kristin Marie Gowin, M.D. (NPI 1033172895), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kristin Marie Gowin, M.D. have ACO affiliation data?

Kristin Marie Gowin, M.D. is shown with ACO affiliation data for Mission Health Partners, LLC (MSSP, ACO ID A2591).

What billing organization is linked to Kristin Marie Gowin, M.D.?

Kristin Marie Gowin, M.D. is linked to ASHEVILLE ARTHRITIS AND OSTEOPOROSIS CENTER, P.A. (billing NPI 1780647578) in the available physician profile data.

Does Kristin Marie Gowin, M.D. have Open Payments data?

Kristin Marie Gowin, M.D. has 105 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.